Crying over spilt milk here but if only we had not had those initial delays with the phase 1 MND trials. We could potentially be well on our way with our own phase 2/3 trial and likely making the Relyvrio trial results redundant anyway. A 40% chance of success for Relyvrio doesn't sound very good now does it?
Crying over spilt milk here but if only we had not had those...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $96.77M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $45.62K | 190.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18200 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 43491 | 5 |
View Market Depth
| Last trade - 15.00pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
0.000 ( 2.77 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 24.5¢ | 24.0¢ | 93977 | ||
| Last updated 15.00pm 29/04/2024 ? | |||||
| PAA (ASX) Chart |